For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
|Articles|January 2, 2022
'Open Your Eyes' documentary to premiere this month
Author(s)Optometry Times Staff Reports, Kerry Gelb, OD
Exciting news from OYE Technology!
Advertisement
Exciting news from
The documentary "Open Your Eyes," created to reframe optometry in the eyes of the world, will officially premiere on iTunes, Apple TV, and Google Play January 28, 2022.
"Open Your Eyes" follows Dr. Kerry Gelb and Chris Maraboli, a podcaster, into the future of health by exploring how America became so sick and how optometrists can now see almost 300 systemic diseases in the eye.
Learn more about the film and
Advertisement
Related to this article
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.
Maria Sampalis, OD, discusses her implementation of the EHR software Barti in her practice.
Aflibercept 8 mg cut RVO injections by up to 3 over 64 weeks in QUASAR, while a pair of additional posters show Amsler gaps in AMD and BRAO-linked stroke risk.
Ryzumvi gained a presbyopia indication in adults based on the phase 3 VEGA-2 and VEGA-3 trials, adding a pharmacologic option for optometrists managing near vision loss.
Enspryng is the first subcutaneous, at-home treatment option for TED and the first interleukin (IL)-6 receptor inhibitor approved in the indication.
Susan Gromacki, OD, MS, FAAO, FSLS, details one of her AAOpt 2026 sessions, titled "Advances in Contact Lens Care for the New Contact Lens Technologies."
Three researchers share the prize for discovering channelrhodopsin, a light-sensitive protein now being tested to restore vision in retinal disease.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
2
FDA approves subcutaneous Enspryng for TED
3
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
4
FAQ: What clinicians should know as SYD-101 heads to FDA advisory committee
5